As on Wednesday, Oncolytics Biotech, Inc (NASDAQ: ONCY) started slowly as it slid -5.19% to $1.28, before settling in for the price of $1.35 at the close. Taking a more long-term approach, ONCY posted a 52-week range of $0.33-$1.51.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 23.13%. Meanwhile, its Annual Earning per share during the time was 23.13%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 19.79%. This publicly-traded company’s shares outstanding now amounts to $100.36 million, simultaneously with a float of $98.09 million. The organization now has a market capitalization sitting at $129.59 million. At the time of writing, stock’s 50-day Moving Average stood at $1.1512, while the 200-day Moving Average is $0.8202.
Oncolytics Biotech, Inc (ONCY) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Oncolytics Biotech, Inc’s current insider ownership accounts for 2.27%, in contrast to 9.65% institutional ownership.
Oncolytics Biotech, Inc (ONCY) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
Oncolytics Biotech, Inc’s EPS increase for this current 12-month fiscal period is 19.79% and is forecasted to reach -0.25 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 9.40% through the next 5 years, which can be compared against the 23.13% growth it accomplished over the previous five years trading on the market.
Oncolytics Biotech, Inc (NASDAQ: ONCY) Trading Performance Indicators
Let’s observe the current performance indicators for Oncolytics Biotech, Inc (ONCY). It’s Quick Ratio in the last reported quarter now stands at 2.88.
In the same vein, ONCY’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.27, a figure that is expected to reach -0.06 in the next quarter, and analysts are predicting that it will be -0.25 at the market close of one year from today.
Technical Analysis of Oncolytics Biotech, Inc (ONCY)
Through scrutinizing the latest numbers posted by the [Oncolytics Biotech, Inc, ONCY], it can be observed that its last 5-days Average volume of 0.92 million was lower the volume of 1.02 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 41.94% While, its Average True Range was 42.70.
Raw Stochastic average of Oncolytics Biotech, Inc (ONCY) in the period of the previous 100 days is set at 80.58%, which indicates a major rise in contrast to 25.81% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0765 that was lower than 0.0911 volatility it exhibited in the past 100-days period.
